L. Degenhardt, A. Ferrari, B. Calabria, W. Hall, R. Norman et al., The Global Epidemiology and Contribution of Cannabis Use and Dependence to the Global Burden of Disease: Results from the GBD 2010 Study, PLoS ONE, vol.187, issue.10, p.76635, 2013.
DOI : 10.1371/journal.pone.0076635.s008

E. Cantor-graae, L. Nordström, and T. Mcneil, Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden, Schizophrenia Research, vol.48, issue.1, pp.69-82, 2001.
DOI : 10.1016/S0920-9964(00)00114-6

H. Myles, N. Myles, and M. Large, Cannabis use in first episode psychosis: Meta-analysis of prevalence, and the time course of initiation and continued use, Australian & New Zealand Journal of Psychiatry, vol.325, issue.3
DOI : 10.1136/bmj.315.7109.629

J. Koskinen, J. Löhönen, H. Koponen, M. Isohanni, and J. Miettunen, Rate of Cannabis Use Disorders in Clinical Samples of Patients With Schizophrenia: A Meta-analysis, Schizophrenia Bulletin, vol.36, issue.6, pp.1115-1145, 2010.
DOI : 10.1093/schbul/sbp031

R. Radhakrishnan, P. Addy, R. Sewell, P. Skosnik, M. Ranganathan et al., Cannabis, cannabinoids and the link with psychosis The effects of drug abuse on the human nervous system, pp.2014-423

N. Solowij and P. Michie, Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia?, J Psychiatry Neurosci, vol.32, pp.30-52, 2007.

P. Fletcher and G. Honey, Schizophrenia, ketamine and cannabis: evidence of overlapping memory deficits, Trends in Cognitive Sciences, vol.10, issue.4, pp.167-74, 2006.
DOI : 10.1016/j.tics.2006.02.008

G. Patrick, J. Straumanis, F. Struve, M. Fitz-gerald, J. Leavitt et al., Reduced P50 auditory gating response in psychiatrically normal chronic marihuana users: a pilot study, Biological Psychiatry, vol.45, issue.10, pp.1307-1319, 1999.
DOI : 10.1016/S0006-3223(98)00155-3

K. Kedzior and M. Martin-iverson, Chronic cannabis use is associated with attention-modulated reduction in prepulse inhibition of the startle reflex in healthy humans, Journal of Psychopharmacology, vol.55, issue.5, pp.471-84, 2006.
DOI : 10.1177/0269881105057516

L. Greenwood, S. Broyd, R. Croft, J. Todd, P. Michie et al., Chronic Effects of Cannabis Use on the Auditory Mismatch Negativity, Biological Psychiatry, vol.75, issue.6, pp.449-58, 2014.
DOI : 10.1016/j.biopsych.2013.05.035

B. Chadwick, M. Miller, and Y. Hurd, Cannabis use during adolescent development: susceptibility to psychiatric illness. Front Psychiatry, p.129, 2013.

C. Henquet, R. Murray, D. Linszen, and J. Van-os, The Environment and Schizophrenia: The Role of Cannabis Use, Schizophrenia Bulletin, vol.31, issue.3, pp.608-620, 2005.
DOI : 10.1093/schbul/sbi027

J. Macleod, R. Oakes, A. Copello, I. Crome, M. Egger et al., Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies, The Lancet, vol.363, issue.9421, pp.1579-88, 2004.
DOI : 10.1016/S0140-6736(04)16200-4

T. Moore, S. Zammit, A. Lingford-hughes, T. Barnes, P. Jones et al., Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review, The Lancet, vol.370, issue.9584, pp.319-347, 2007.
DOI : 10.1016/S0140-6736(07)61162-3

E. Manrique-garcia, S. Zammit, C. Dalman, T. Hemmingsson, S. Andreasson et al., Cannabis, schizophrenia and other non-affective psychoses: 35 years of follow-up of a population-based cohort, Psychological Medicine, vol.42, issue.06, pp.1321-1329, 2012.
DOI : 10.1192/bjp.157.1.25

A. Mané, M. Fernández-expósito, D. Bergé, L. Gómez-pérez, A. Sabaté et al., Relationship between cannabis and psychosis: Reasons for use and associated clinical variables, Psychiatry Research, vol.229, issue.1-2, pp.70-74, 2015.
DOI : 10.1016/j.psychres.2015.07.070

A. Green, M. Tohen, R. Hamer, S. Strakowski, J. Lieberman et al., First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol, Schizophrenia Research, vol.66, issue.2-3, pp.125-160, 2004.
DOI : 10.1016/j.schres.2003.08.001

S. Van-mastrigt, J. Addington, and D. Addington, Substance misuse at presentation to an early psychosis program, Social Psychiatry and Psychiatric Epidemiology, vol.39, issue.1, pp.69-72, 2004.
DOI : 10.1007/s00127-004-0713-0

M. Large, S. Sharma, M. Compton, T. Slade, and O. Nielssen, Cannabis Use and Earlier Onset of Psychosis, Archives of General Psychiatry, vol.68, issue.6, pp.555-61, 2011.
DOI : 10.1001/archgenpsychiatry.2011.5

S. Sevy, D. Robinson, S. Holloway, J. Alvir, M. Woerner et al., Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder, Acta Psychiatr Scand, vol.104, pp.367-74, 2001.

T. Wobrock, P. Falkai, T. Schneider-axmann, T. Hasan, S. Galderisi et al., Comorbid substance abuse in first-episode schizophrenia: Effects on cognition and psychopathology in the EUFEST study, Schizophrenia Research, vol.147, issue.1, pp.132-141, 2013.
DOI : 10.1016/j.schres.2013.03.001

S. Zammit, T. Moore, A. Lingford-hughes, T. Barnes, P. Jones et al., Effects of cannabis use on outcomes of psychotic disorders: systematic review, The British Journal of Psychiatry, vol.193, issue.5, pp.357-63, 2008.
DOI : 10.1192/bjp.bp.107.046375

G. Bersani, V. Orlandi, S. Gherardelli, and P. Pancheri, Cannabis and Neurological Soft Signs in Schizophrenia: Absence of Relationship and Influence on Psychopathology, Psychopathology, vol.35, issue.5, pp.289-95, 2002.
DOI : 10.1159/000067064

J. Boydell, K. Dean, R. Dutta, E. Giouroukou, P. Fearon et al., A comparison of symptoms and family history in schizophrenia with and without prior cannabis use: Implications for the concept of cannabis psychosis, Schizophrenia Research, vol.93, issue.1-3, pp.203-213, 2007.
DOI : 10.1016/j.schres.2007.03.014

J. Stirling, S. Lewis, R. Hopkins, and C. White, Cannabis use prior to first onset psychosis predicts spared neurocognition at 10-year follow-up, Schizophrenia Research, vol.75, issue.1, pp.135-142, 2005.
DOI : 10.1016/j.schres.2004.10.006

D. Van-dijk, M. Koeter, R. Hijman, R. Kahn, and W. Van-den-brink, Effect of cannabis use on the course of schizophrenia in male patients: A prospective cohort study, Schizophrenia Research, vol.137, issue.1-3, pp.50-57, 2012.
DOI : 10.1016/j.schres.2012.01.016

P. Gupta, K. Mullin, O. Nielssen, A. Harris, and M. Large, Do former substance users with psychosis differ in their symptoms or function from non-substance users? A systematic meta-analysis, Australian & New Zealand Journal of Psychiatry, vol.45, issue.407, pp.524-561, 2013.
DOI : 10.1016/S0140-6736(07)61162-3

. Sarrazin, A clinical comparison of schizophrenia with and without pre-onset cannabis use disorder: a retrospective cohort study using categorical and dimensional approaches, Annals of General Psychiatry, vol.65, issue.4, p.44, 2015.
DOI : 10.1186/s12991-015-0083-x
URL : https://hal.archives-ouvertes.fr/inserm-01254135

I. Baeza, M. Graell, D. Moreno, J. Castro-fornieles, M. Parellada et al., Cannabis use in children and adolescents with first episode psychosis: Influence on psychopathology and short-term outcome (CAFEPS study), Schizophrenia Research, vol.113, issue.2-3, pp.129-166, 2009.
DOI : 10.1016/j.schres.2009.04.005

M. Compton, B. Broussard, C. Ramsay, and T. Stewart, Pre-illness cannabis use and the early course of nonaffective psychotic disorders: Associations with premorbid functioning, the prodrome, and mode of onset of psychosis, Schizophrenia Research, vol.126, issue.1-3, pp.71-77, 2011.
DOI : 10.1016/j.schres.2010.10.005

D. Foti, R. Kotov, L. Guey, and E. Bromet, Cannabis Use and the Course of Schizophrenia: 10-Year Follow-Up After First Hospitalization, American Journal of Psychiatry, vol.167, issue.8, pp.987-93, 2010.
DOI : 10.1176/appi.ajp.2010.09020189

G. Rubio, J. Marín-lozano, F. Ferre, I. Martínez-gras, R. Rodriguez-jimenez et al., Psychopathologic differences between cannabis-induced psychoses and recent-onset primary psychoses with abuse of cannabis, Comprehensive Psychiatry, vol.53, issue.8, pp.1063-70, 2012.
DOI : 10.1016/j.comppsych.2012.04.013

M. Ruiz-veguilla, M. Barrigón, L. Hernández, J. Rubio, M. Gurpegui et al., Dose???response effect between cannabis use and psychosis liability in a non-clinical population: Evidence from a snowball sample, Journal of Psychiatric Research, vol.47, issue.8, pp.1036-1079, 2013.
DOI : 10.1016/j.jpsychires.2013.03.003

A. Cardno, P. Sham, R. Murray, and P. Mcguffin, Twin study of symptom dimensions in psychoses, The British Journal of Psychiatry, vol.179, issue.1, pp.39-45, 2001.
DOI : 10.1192/bjp.179.1.39

A. Mcintosh, A. Forrester, S. Lawrie, M. Byrne, A. Harper et al., A factor model of the functional psychoses and the relationship of factors to clinical variables and brain morphology, Psychological Medicine, vol.31, issue.1, pp.159-71, 2001.
DOI : 10.1017/S0033291799003177

A. Serretti, M. Rietschel, E. Lattuada, H. Krauss, T. Schulze et al., Major psychoses symptomatology: factor analysis of 2241 psychotic subjects, European Archives of Psychiatry and Clinical Neuroscience, vol.251, issue.4, pp.193-201, 2001.
DOI : 10.1007/s004060170040

J. Van-os, M. Marcelis, P. Sham, P. Jones, K. Gilvarry et al., Psychopathological syndromes and familial morbid risk of psychosis, The British Journal of Psychiatry, vol.170, issue.3, pp.241-247, 1997.
DOI : 10.1192/bjp.170.3.241

M. Preisig, B. Fenton, M. Matthey, A. Berney, and F. Ferrero, Diagnostic interview for genetic studies (DIGS): inter-rater and test-retest reliability of the French version, European Archives of Psychiatry and Clinical Neuroscience, vol.249, issue.4, pp.74-179, 1999.
DOI : 10.1007/s004060050084

M. Maxwell, Family interview for genetic studies Intramural Research Program, Clinical Neurogenetic Branch, 1992.

P. Mcguffin, A. Farmer, and I. Harvey, A Polydiagnostic Application of Operational Criteria in Studies of Psychotic Illness, Archives of General Psychiatry, vol.48, issue.8, pp.764-70, 1991.
DOI : 10.1001/archpsyc.1991.01810320088015

W. Hall, Cannabis use and psychosis, Drug and Alcohol Review, vol.17, issue.4, pp.433-477, 1998.
DOI : 10.1080/09595239800187271

M. Large, K. Mullin, P. Gupta, A. Harris, and O. Nielssen, Systematic meta-analysis of outcomes associated with psychosis and co-morbid substance use, Australian & New Zealand Journal of Psychiatry, vol.38, issue.407
DOI : 10.1016/S0140-6736(07)61602-X

M. Arendt, P. Mortensen, R. Rosenberg, C. Pedersen, and B. Waltoft, Familial Predisposition for Psychiatric Disorder, Archives of General Psychiatry, vol.65, issue.11, pp.1269-74, 2008.
DOI : 10.1001/archpsyc.65.11.1269

M. Barrigón, M. Gurpegui, M. Ruiz-veguilla, F. Diaz, M. Anguita et al., Temporal relationship of first-episode non-affective psychosis with cannabis use: A clinical verification of an epidemiological hypothesis, Journal of Psychiatric Research, vol.44, issue.7, pp.413-433, 2010.
DOI : 10.1016/j.jpsychires.2009.10.004

G. Sugranyes, I. Flamarique, E. Parellada, I. Baeza, J. Goti et al., Cannabis use and age of diagnosis of schizophrenia, European Psychiatry, vol.24, issue.5, pp.282-288, 2009.
DOI : 10.1016/j.eurpsy.2009.01.002

M. Arendt, R. Rosenberg, L. Foldager, G. Perto, and P. Munk-jørgensen, Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases, The British Journal of Psychiatry, vol.187, issue.6, pp.510-515, 2005.
DOI : 10.1192/bjp.187.6.510

M. Compton, M. Kelley, C. Ramsay, M. Pringle, S. Goulding et al., Association of Pre-Onset Cannabis, Alcohol, and Tobacco Use With Age at Onset of Prodrome and Age at Onset of Psychosis in First-Episode Patients, American Journal of Psychiatry, vol.166, issue.11, pp.1251-1258, 2009.
DOI : 10.1176/appi.ajp.2009.09030311

J. Galvez-buccollini, A. Proal, V. Tomaselli, M. Trachtenberg, C. Coconcea et al., Association between age at onset of psychosis and age at onset of cannabis use in non-affective psychosis, Schizophrenia Research, vol.139, issue.1-3, pp.157-60, 2012.
DOI : 10.1016/j.schres.2012.06.007

B. Cuffel, K. Heithoff, and W. Lawson, Correlates of Patterns of Substance Abuse Among Patients With Schizophrenia, Psychiatric Services, vol.44, issue.3, pp.247-51, 1993.
DOI : 10.1176/ps.44.3.247

B. Kovasznay, E. Bromet, J. Schwartz, R. R. Lavelle, J. Brandon et al., Substance Abuse and Onset of Psychotic Illness, Psychiatric Services, vol.44, issue.6, pp.567-71, 1993.
DOI : 10.1176/ps.44.6.567

S. Zisook, R. Heaton, J. Moranville, J. Kuck, T. Jernigan et al., Past substance abuse and clinical course of schizophrenia, Am J Psychiatry, vol.149, pp.552-555, 1992.

P. Auquier, C. Lançon, F. Rouillon, and M. Lader, Mortality in schizophrenia, Pharmacoepidemiology and Drug Safety, vol.3, issue.12, pp.1308-1320, 2007.
DOI : 10.1002/pds.1496

M. Soyka, M. Albus, B. Immler, N. Kathmann, and H. Hippius, Psychopathology in dual diagnosis and non-addicted schizophrenics - are there differences?, European Archives of Psychiatry and Clinical Neuroscience, vol.251, issue.5, pp.232-240, 2001.
DOI : 10.1007/s004060170032

Z. Makkos, L. Fejes, G. Inczédy-farkas, A. Kassai-farkas, G. Faludi et al., Psychopharmacological comparison of schizophrenia spectrum disorder with and without cannabis dependency, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.35, issue.1, pp.212-219, 2011.
DOI : 10.1016/j.pnpbp.2010.11.007

P. Mcguire, P. Jones, I. Harvey, M. Williams, P. Mcguffin et al., Morbid risk of schizophrenia for relatives of patients with cannabis-associated psychosis, Schizophrenia Research, vol.15, issue.3, pp.277-81, 1995.
DOI : 10.1016/0920-9964(94)00053-B

T. Barnes, S. Mutsatsa, S. Hutton, H. Watt, and E. Joyce, Comorbid substance use and age at onset of schizophrenia, The British Journal of Psychiatry, vol.188, issue.3, pp.237-279, 2006.
DOI : 10.1192/bjp.bp.104.007237

J. Dequardo, C. Carpenter, and R. Tandon, Patterns of substance abuse in Schizophrenia: Nature and significance, Journal of Psychiatric Research, vol.28, issue.3, pp.267-75, 1994.
DOI : 10.1016/0022-3956(94)90010-8

J. Rabinowitz, E. Bromet, J. Lavelle, G. Carlson, B. Kovasznay et al., Prevalence and severity of substance use disorders and onset of psychosis in first-admission psychotic patients, Psychological Medicine, vol.28, issue.6, pp.1411-1420, 1998.
DOI : 10.1017/S0033291798007399

D. Caspari, Cannabis and schizophrenia: results of a follow-up study, European Archives of Psychiatry and Clinical Neuroscience, vol.249, issue.1, pp.45-54, 1999.
DOI : 10.1007/s004060050064

L. Degenhardt, C. Tennant, S. Gilmour, D. Schofield, L. Nash et al., The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study, Psychological Medicine, vol.37, issue.07, pp.927-961, 2007.
DOI : 10.1017/S0033291707009956

A. Grech, J. Van-os, P. Jones, S. Lewis, and R. Murray, Cannabis use and outcome of recent onset psychosis, European Psychiatry, vol.20, issue.4, pp.349-53, 2005.
DOI : 10.1016/j.eurpsy.2004.09.013

M. Compton, A. Furman, and N. Kaslow, Lower negative symptom scores among cannabis-dependent patients with schizophrenia-spectrum disorders: preliminary evidence from an African American first-episode sample, Schizophrenia Research, vol.71, issue.1, pp.61-65, 2004.
DOI : 10.1016/j.schres.2004.01.005

A. Talamo, F. Centorrino, L. Tondo, A. Dimitri, J. Hennen et al., Comorbid substance-use in schizophrenia: Relation to positive and negative symptoms, Schizophrenia Research, vol.86, issue.1-3, pp.251-256, 2006.
DOI : 10.1016/j.schres.2006.04.004

A. Berney, M. Preisig, M. Matthey, F. Ferrero, and B. Fenton, Diagnostic interview for genetic studies (DIGS): inter-rater and test-retest reliability of alcohol and drug diagnoses, Drug and Alcohol Dependence, vol.65, issue.2, pp.149-58, 2002.
DOI : 10.1016/S0376-8716(01)00156-9